2023-07-01 13524591 2024-06-30 13524591 2023-07-01 2024-06-30 13524591 2023-06-30 13524591 2022-07-01 2023-06-30 13524591 uk-core:WithinOneYear 2023-06-30 13524591 uk-core:WithinOneYear 2024-06-30 13524591 uk-core:ShareCapital 2024-06-30 13524591 uk-core:ShareCapital 2023-06-30 13524591 uk-bus:Director1 2023-07-01 2024-06-30 iso4217:GBP xbrli:pure 13524591 uk-bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 13524591 uk-bus:FRS102 2023-07-01 2024-06-30 13524591 uk-bus:FilletedAccounts 2023-07-01 2024-06-30 13524591 uk-bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30
VSAT Pharma Ltd
Registered Number:13524591
For the year ended 30 June 2024
England and Wales
Unaudited Financial Statements
2
For the year ended 30 June 2024
VSAT Pharma Ltd
Contents Page
1
Statement of Financial Position
2
Notes to the Financial Statements
3
Registered Number :
13524591
As at 30 June 2024
VSAT Pharma Ltd
Statement of Financial Position
£
£
2023
2024
Notes
Current assets
2,667
Cash and cash equivalents
7,702
7,702
2,667
Trade and other payables: amounts falling due within one year
(2,664)
(7,699)
2
3
3
Net current assets
Total assets less current liabilities
3
3
3
Net assets
3
Capital and reserves
Called up share capital
3
3
3
3
Shareholders' funds
For the year ended 30 June 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial
year and of its profit or loss for each financial year in accordance with the requirements of Section 394 and 395 and which
otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the
company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Mr Vahid Satei Director
These financial statements were approved and authorised for issue by the Board on 01 August 2024 and were signed by:
The notes form part of these financial statements
1 of 2
4
For the year ended 30 June 2024
VSAT Pharma Ltd
Notes to the Financial Statements
Statutory Information
VSAT Pharma Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 13524591.
Registered address:
19 Beaumont Court
Winlaton
NE21 6BF
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial Reporting Standard
102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the Companies Act 2006. The financial
statements have been prepared under the historical costs convention as modified by the revaluation of certain assets.
2. Trade and other payables: amounts falling due within one year
2023
2024
£
£
Trade creditors
720
-
Taxation and social security
6,979
2,664
7,699
2,664
3. Average number of persons employed
During the year the average number of employees was 1 (2023 : 1)
2 of 2